Go Pro

Spinnaker Trust Sells 4,957 Shares of UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Spinnaker Trust reduced its UnitedHealth Group stake by 18%, selling 4,957 shares during the second quarter and retaining 22,525 shares valued at approximately $9.36 million.
  • Institutional ownership remains high at 87.86%, with major investors including BlackRock increasing its position while Norges Bank, Legal & General, and Jupiter Topco initiated sizable stakes.
  • Analysts maintain a “Moderate Buy” consensus with an average price target of $456.56. UnitedHealth also reported quarterly earnings above estimates and declared a $2.32 quarterly dividend, equivalent to a 2.4% yield.
  • Five stocks we like better than UnitedHealth Group.

Spinnaker Trust lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 18.0% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 22,525 shares of the healthcare conglomerate's stock after selling 4,957 shares during the period. Spinnaker Trust's holdings in UnitedHealth Group were worth $9,362,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Norges Bank bought a new stake in UnitedHealth Group in the 4th quarter valued at $4,376,167,000. Corient Private Wealth LP bought a new position in UnitedHealth Group during the second quarter worth about $245,516,000. Legal & General Group Plc bought a new position in shares of UnitedHealth Group during the second quarter worth approximately $2,444,928,000. Jupiter Topco LLC bought a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $2,019,844,000. Finally, BlackRock Inc. increased its stake in UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock worth $31,946,594,000 after acquiring an additional 3,395,530 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on UNH shares. Erste Group Bank cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Thursday. BMO Capital Markets set a $512.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Wall Street Zen upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Saturday, August 8th. Piper Sandler set a $477.00 target price on UnitedHealth Group in a research note on Thursday, July 16th. Finally, UBS Group raised their price objective on UnitedHealth Group from $460.00 to $490.00 and gave the company a "buy" rating in a research note on Friday, July 17th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus target price of $456.56.

Read Our Latest Report on UnitedHealth Group

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 1,169 shares of the firm's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company's stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.19% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $393.99 on Friday. The company has a market capitalization of $353.64 billion, a PE ratio of 25.35, a P/E/G ratio of 1.36 and a beta of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. The company has a 50 day simple moving average of $413.28 and a two-hundred day simple moving average of $360.11.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating analysts' consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. During the same period in the prior year, the firm posted $4.08 EPS. The company's quarterly revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be given a $2.32 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group's dividend payout ratio (DPR) is 59.72%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines